tenoxicam

ApprovedSmall molecule

NNational Taiwan University Hospital

tenoxicam is one of 60 small molecule programs targeting Migraine. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

MigraineActive, not recruiting

OsteoarthritisActive, not recruiting

MigraineApproved

Active, not recruiting

OsteoarthritisPhase 1

Active, not recruiting

Competition

Competitive Landscape

778 competitors in Osteoarthritis

#DrugCompanyPhaseTrials

tenoxicam

NNational Taiwan University Hospital

Approved

2 2

Ilaris

Novartis

Preclinical

2 3

Toradol

Roche

Preclinical

1 4

Voltaren

CCerimon Pharmaceuticals

Preclinical

4 5

Cataflam

Platelet Rich Plasma

25 7

Enbrel

IImmunex

Preclinical

2 8

Glucophage

Boehringer Ingelheim

Preclinical

1 9

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Preclinical

1 10

Paracetamol

GSK

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Osteoarthritis2 trials

Intra-articular Tenoxicam Versus Triamcinolone Acetonide in Knee Osteoarthritis Management

Completed·—·N/A·NCT07194135·100 enrolled

Injection of Tenoxicam Versus Arthrocentesis Alone in the Treatment of Temporomandibular Joint Osteoarthritis

Completed·—·Phase 1·NCT05497570·30 enrolled

Analgesic Efficacy1 trial

Comparison of Postoperative Analgesic Efficacy of Intravenous Dexketoprofen Trometamol With Tenoxicam

Unknown status·TTC Erciyes University·Phase 4·NCT02160236·90 enrolled

Analgesia1 trial

Tenoxicam for Intrapartum Analgesia

Unknown status·—·Phase 2·NCT02549118·100 enrolled

Efficacy1 trial

Influence of CYP2C9 Genotype on Clinical Efficacy of Tenoxicam

Completed·UUniversity of Sao Paulo·Phase 4·NCT04182191·89 enrolled

Intravenous1 trial

Efficacy of Intravenous Dexketoprofen and Tenoxicam on Propofol Associated Injection Pain

Completed·OOrdu University·Phase 4·NCT02285972·118 enrolled

3 more indications

Gastrointestinal Function1 trial

Effects on Recovery of Postoperative Gastrointestinal Function With Multimodal Analgesia

Unknown status·NNational Taiwan University Hospital·N/A·NCT04314310·30 enrolled

Migraine1 trial

Comparision of the Analgesic Effects of Intravenous Ibuprofen and Tenoxicam in Acute Migraine Attack

Active, not recruiting·HHaydarpasa Numune Training and Research Hospital·Phase 4·NCT06786650·100 enrolled

Temporomandibular Joint Internal Derangement1 trial

Effect of Intraarticular Injection of Tenoxicam and Hyaluronic Acid Versus Platelet-Rich Plasma and Hyaluronic Acid in Temporomandibular Joint Internal Derangement

Active, not recruiting·MMansoura University·Phase 1/2·NCT06572904·60 enrolled

Sources

References

[1]
ClinicalTrials.gov — 9 trial records for tenoxicam. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — tenoxicam compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for tenoxicam. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — National Taiwan University Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: NNational Taiwan University Hospital

tenoxicam

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Osteoarthritis2 trials

Analgesic Efficacy1 trial

Analgesia1 trial

Efficacy1 trial

Intravenous1 trial

Gastrointestinal Function1 trial

Migraine1 trial

Temporomandibular Joint Internal Derangement1 trial

References

Drug Info

Quick Facts

Related News